The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects
Open accessAbstract
Background and aims Abdominal fat accumulation (visceral/hepatic) has been associated with hepatic insulin resistance (IR) in obesity and type 2 diabetes (T2DM). We examined the relationship between visceral/hepatic fat accumulation and hepatic IR/accelerated gluconeogenesis (GNG).Methods In 14 normal glucose tolerant (NGT) (body mass index [BMI] = 25 +/- 1 kg/m(2)) and 43 T2DM (24 nonobese, BMI = 26 +/- 1; 19 obese, BMI = 32 +/- 1 kg/m(2)) subjects, we measured endogenous (hepatic) glucose production (3-(3)H-glucose) and GNG ((2)H(2)O) in the basal state and during 240 pmol/m(2)/min euglycemic-hyperinsulinemic clamp, and liver (LF) subcutaneous (SAT)/visceral (VAT) fat content by magnetic resonance spectroscopy/magnetic resonance imaging.Results LF was increased in lean T2DM compared with lean NGT (18% +/- 3% vs 9% +/- 2%, P < .03), but was similar in lean T2DM and obese T2DM (18% +/- 3% vs 22% +/- 3%; P = NS). Both VAT and SAT increased progressively from lean NGT to lean T2DM to obese T2DM. T2DM had increased basal endogenous glucose production (EGP) (NGT, 15.1 +/- 0.5; lean T2DM, 16.3 +/- 0.4; obese T2DM, 17.2 +/- 0.6 micromol/min/kg(ffm); P = .02) and basal GNG flux (NGT, 8.6 +/- 0.4; lean T2DM, 9.6 +/- 0.4; obese T2DM, 11.1 +/- 0.6 micromol/min/kg(ffm); P = .02). Basal hepatic IR index (EGP x fasting plasma insulin) was increased in T2DM (NGT, 816 +/- 54; lean T2DM, 1252 +/- 164; obese T2DM, 1810 +/- 210; P = .007). In T2DM, after accounting for age, sex, and BMI, both LF and VAT, but not SAT, were correlated significantly (P < .05) with basal hepatic IR and residual EGP during insulin clamp. Basal percentage of GNG and GNG flux were correlated positively with VAT (P < .05), but not with LF. LF, but not VAT, was correlated with fasting insulin, insulin-stimulated glucose disposal, and impaired FFA suppression by insulin (all P < .05).Conclusions Abdominal adiposity significantly affects both lipid (FFA) and glucose metabolism. Excess VAT primarily increases GNG flux. Both VAT and LF are associated with hepatic IR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Except for a recent study of Gastaldelli et al, 17 who found no difference in insulin clearance between lean normal subjects and lean or obese type 2 diabetic patients, there are no studies in which carefully matched groups of type 2 diabetic patients and nondiabetic subjects would have been compared with respect to liver fat, hepatic insulin sensitivity, and insulin clearance.”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [17]
In the citing paper
“In small groups of diabetic patients, insulin clearance has reported to be normal, 16 -18 decreased, 19,20 or even increased.21”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Association of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli‐Labate, A. M., Bianchi, G. P., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,570
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322
Insulin resistance: a metabolic pathway to chronic liver disease
Bugianesi, E., McCullough, A. J., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20920 · Cited by 900
Measurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812
Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia · doi:10.1007/s00125-005-1682-x · Cited by 770
Flagged first, then by citations
2 of the 43 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Matsuda, 1997, Relationship between insulin sensitivity in adipose tissue, liver, muscle and components of the insulin resistance syndrome, Diabetes, 46, 68A
Cited by
Sorted by citations
Items 301–400 of 629
Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells
Carpéné, C., García‐Vicente, S., Serrano, M., Marti, L., Belles, C., Royo, M., Galitzky, J., Zorzano, A., & Testar, X. (2017) · World Journal of Diabetes · doi:10.4239/wjd.v8.i4.143 · Cited by 26
Pregnancy-induced Cardiovascular Pathologies: Importance of Structural Components and Lipids
Aleksenko, L., & Quaye, I. K. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.05.014 · Cited by 26
Zhai, T., Xu, W., Liu, Y., Qian, K., Xiong, Y., & Chen, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2313641 · Cited by 26
Nikbaf‐Shandiz, M., Tutunchi, H., Khoshbaten, M., Nazari‐Bonab, H., & Ebrahimi‐Mameghani, M. (2022) · Food & Function · doi:10.1039/d2fo01280d · Cited by 26
Body Fat Distribution and Risk Factors for Fibrosis in Patients with Alcoholic Liver Disease
Naveau, S., Dobrin, A.-S., Balian, A., Njiké‐Nakseu, M., Nohra, P., Asnacios, A., Prevot, S., & Perlemuter, G. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2012.01927.x · Cited by 26
Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: The Hidden Epidemic
Ismail, M. H. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182018598 · Cited by 26
Bello, O., Mohandas, C., Shojaee‐Moradie, F., Jackson, N., Hakim, O., Alberti, K. G. M. M., Peacock, J. L., Umpleby, A. M., Amiel, S. A., & Goff, L. M. (2019) · Diabetologia · doi:10.1007/s00125-019-4820-6 · Cited by 27
Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention
Linder, K., Willmann, C., Kantartzis, K., Machann, J., Schick, F., Graf, M., Kümmerle, S., Häring, H., Fritsche, A., Stefan, N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-38002-7 · Cited by 27
Gao, J., Xiao, H., Li, J., Guo, X., Cai, W., & Li, D. (2019) · Nutrients · doi:10.3390/nu11071699 · Cited by 26
Macfarlane, D. P., Raubenheimer, P. J., Preston, T., Gray, C. D., Bastin, M. E., Marshall, I., Iredale, J. P., Andrew, R., & Walker, B. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00030.2014 · Cited by 25
Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics
Khashper, A., Gaspar, T., Azencot, M., Dobrecky‐Mery, I., Peled, N., Lewis, B. S., & Halon, D. A. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.05.059 · Cited by 25
Han, H., Hu, C.-X., Wang, L., Zhang, G., Liu, S., Li, F., Sun, D., & Hu, S. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1308-9 · Cited by 25
Won, G., Choi, S., Kang, C.-H., & Kim, G. (2021) · Microorganisms · doi:10.3390/microorganisms9061139 · Cited by 25
Camastra, S., & Ferrannini, E. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09708-3 · Cited by 27
Mittendorfer, B., Patterson, B. W., Haire-Joshu, D. L., Cahill, A. G., Cade, W. T., Stein, R. I., & Klein, S. (2023) · Diabetes Care · doi:10.2337/dc22-1894 · Cited by 28
Portillo-Sánchez, P., Yavuz, S., Bril, F., & Cusi, K. J. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0229-3 · Cited by 25
Posadas‐Sánchez, R., Ocampo-Arcos, W. A., López-Uribe, Á. R., Posadas‐Romero, C., Villarreal-Molina, M. T., León, E. Á., Pérez‐Hernández, N., Rodrı́guez-Pérez, J. M., Cardoso-Saldaña, G. C., Medina-Urrutia, A. X., et al. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.12.010 · Cited by 25
Li, X., Xia, M., Ma, H., Hu, Y., Yan, H., He, W., Lin, H., Zhao, N., Gao, J., & Gao, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065210 · Cited by 25
Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease
von Loeffelholz, C., Horn, P., Birkenfeld, A. L., Claus, R. A., Metzing, U. B., Döcke, S., Jahreis, G., Heller, R., Hoppe, S., Stockmann, M., et al. (2016) · Journal of Investigative Surgery · doi:10.3109/08941939.2016.1149640 · Cited by 25
Simões, I. C. M., Janikiewicz, J., Bauer, J., Karkucińska‐Więckowska, A., Kalinowski, P., Dobrzyń, A., Wolski, A., Pronicki, M., Zieniewicz, K., Dobrzyń, P., et al. (2019) · Nutrients · doi:10.3390/nu11122871 · Cited by 27
Human Adipose Tissue Metabolism in Obesity
Lin, S., & Jensen, M. D. (2025) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes25025 · Cited by 25
Liu, P., Li, S., Cang, X., Huang, J., Wu, X., Yan, J., Chen, L., Cui, S., & Ye, X. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.01.018 · Cited by 24
Roncero‐Ramos, I., Gutierrez-Mariscal, F. M., Gómez-Delgado, F., Villasanta‐Gonzalez, A., Torres-Peña, J. D., de la Cruz, S., Rangel-Zúñiga, O. A., Luque, R. M., Ordovás, J. M., Delgado‐Lista, J., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.07.001 · Cited by 24
Hepatic fat is not associated with β-cell function or postprandial free fatty acid response
Rijkelijkhuizen, J. M., Doesburg, T., Girman, C. J., Mari, A., Rhodes, T., Gastaldelli, A., Nijpels, G., & Dekker, J. M. (2009) · Metabolism · doi:10.1016/j.metabol.2008.09.013 · Cited by 24
Yang, M., Deng, K., Pan, M., Zhang, Y., Sampath, W. W. H. A., Zhang, W., & Mai, K. (2019) · Aquaculture Nutrition · doi:10.1111/anu.13013 · Cited by 26
Currenti, W., Losavio, F., Quiete, S., Alanazi, A. M., Messina, G., Polito, R., Ciolli, F., Zappalà, R. S., Galvano, F., & Cincione, R. I. (2023) · Nutrients · doi:10.3390/nu16010095 · Cited by 23
Ghrelin-ghrelinO-acyltransferase system in the pathogenesis of nonalcoholic fatty liver disease
Zhang, S., & Fan, X. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i11.3214 · Cited by 23
Calorie restriction and reversal of type 2 diabetes
Taylor, R. (2016) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2016.1239525 · Cited by 24
Adeva‐Andany, M. M., Domínguez-Montero, A., Adeva-Contreras, L., Fernández‐Fernández, C., Carneiro-Freire, N., & González-Lucán, M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399820666230816111624 · Cited by 25
Role of fatty liver in the association between obesity and reduced hepatic insulin clearance
Matsubayashi, Y., Yoshida, A., Suganami, H., Ishiguro, H., Yamamoto, M., Fujihara, K., Kodama, S., Tanaka, S., Kaku, K., & Sone, H. (2017) · Diabetes & Metabolism · doi:10.1016/j.diabet.2017.12.003 · Cited by 23
Sargeant, J. A., Bawden, S., Aithal, G. P., Simpson, E. J., Macdonald, I. A., Turner, M. C., Cegielski, J., Smith, K., Dorling, J. L., Gowland, P. A., et al. (2018) · European Journal of Applied Physiology · doi:10.1007/s00421-018-3818-y · Cited by 25
Julián, M. T., Pera, G., Soldevila, B., Caballería, L., Julve, J., Puig-Jové, C., Morillas, R. M., Torán‐Monserrat, P., Expósito, C., Puig‐Domingo, M., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1240 · Cited by 22
Xie, Y., Zhang, Y., Qin, P., Ping, Z., Wang, C., Peng, X., Chen, H., Zhao, D., Xu, S., Wang, L., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.10.020 · Cited by 22
Visceral adipose tissue area is associated with coronary stenosis and noncalcified plaques
Kang, S. J., Kim, D., Park, H.-K., Choi, S. H., Choi, S.-Y., Lee, W., Kim, J. S., & Cho, S.-H. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.105 · Cited by 22
Goto, R., Kamimura, K., Shinagawa‐Kobayashi, Y., Sakai, N., Nagoya, T., Niwa, Y., Ko, M., Ogawa, K., Inoue, R., Yokoo, T., et al. (2019) · FEBS Open Bio · doi:10.1002/2211-5463.12598 · Cited by 22
Sharma, A. R., Leiva, E. G., Kalavalapalli, S., Lomonaco, R., MARANGI, S. A., SAENZ, E. V., Gonzalez, M. A., Rocha, A. O., CUERVO-PARDO, N., Rosenberg, J. T., et al. (2024) · Obesity · doi:10.1002/oby.24130 · Cited by 21
Metabolic determinants of NAFLD in adults with type 1 diabetes
Serdarova, M. S., Dimova, R. B., Chakarova, N. Y., Grozeva, G. G., Todorova, A., Tsarkova, P., Marinova, C., Popov, D., Mateva, L., & Tankova, T. I. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109819 · Cited by 21
Busch, C. B. E., Meiring, S., van Baar, A. C. G., Gastaldelli, A., DeFronzo, R. A., Mingrone, G., Hagen, M., White, K., Rajagopalan, H., Nieuwdorp, M., et al. (2024) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2024.01.031 · Cited by 21
Cornford, A. S., Hinko, A., Nelson, R. K., Barkan, A. L., & Horowitz, J. F. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2012-0266 · Cited by 21
Narayanan, J. M., & Jesudoss, V. A. S. (2016) · General Physiology and Biophysics · doi:10.4149/gpb_2015041 · Cited by 21
Angelini, G., Salinari, S., BERTUZZI, A., Iaconelli, A., & Mingrone, G. (2018) · Communications Biology · doi:10.1038/s42003-018-0069-8 · Cited by 21
Barbosa-Yañez, R. L., Dambeck, U., Li, L., Machann, J., Kabisch, S., & Pfeiffer, A. F. H. (2018) · Nutrients · doi:10.3390/nu10121859 · Cited by 22
Myocardial Fat Accumulation Is Independent of Measures of Insulin Sensitivity
Muniyappa, R., Noureldin, R., Ouwerkerk, R., Liu, E. Y., Madan, R., Abel, B. S., Mullins, K. P., Walter, M. F., Skarulis, M. C., & Gharib, A. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1139 · Cited by 21
O’Donovan, S. D., Lenz, M., Vink, R., Roumans, N. J. T., de Kok, T. M. C. M., Mariman, E. C. M., Peeters, R., van Riel, N. A. W., van Baak, M. A., & Arts, I. C. W. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007400 · Cited by 22
Zhang, K., Zhu, H., Wang, L., Yang, H., Pan, H., & Gong, F. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01372-9 · Cited by 20
Wang, R., Zhang, X., Ren, H. C., Zhou, H., Yuan, Y., Chai, Y., & Hou, X. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.987804 · Cited by 25
Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
Shao, Y., Chen, S., Liu, H., & Liu, J. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00748-x · Cited by 20
de Soysa, A. K. H., Langaas, M., Jakic, A., Shojaee‐Moradie, F., Umpleby, A. M., Grill, V., & Mostad, I. L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248247 · Cited by 19
New Horizons: Emerging Antidiabetic Medications
Mingrone, G., Castagneto‐Gissey, L., & Bornstein, S. R. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac499 · Cited by 20
Bugianesi, E., & Gastaldelli, A. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.010 · Cited by 19
Ning, H., Sun, Z., Liu, Y., Liu, L., Hao, L., Ye, Y., Feng, R., Li, J., Li, Y., Chu, X., et al. (2016) · Nutrients · doi:10.3390/nu8040227 · Cited by 19
Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes
Barchetta, I., Angelico, F., Ben, M. D., Martino, M. D., Cimini, F. A., Bertoccini, L., Polimeni, L., Catalano, C., Fraioli, A., Vescovo, R. D., et al. (2016) · Clinical Science · doi:10.1042/cs20160348 · Cited by 19
Luo, K., Wang, X., & Zhang, G. (2019) · Food & Function · doi:10.1039/c9fo00798a · Cited by 19
Reed, R. M., Nevitt, S. J., Kemp, G. J., Cuthbertson, D. J., Whyte, M., & Goff, L. M. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01797-5 · Cited by 17
Baltadjiev, A. G., & Baltadjiev, G. (2011) · Folia Medica · doi:10.2478/v10153-011-0057-y · Cited by 18
Lei, H., Chen, X., Liu, S., & Chen, Z. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2016.0361 · Cited by 18
Yan, H., Guo, H., Cheng, D., Kou, R., Zhang, C., & Si, J. (2018) · Environmental Toxicology · doi:10.1002/tox.22562 · Cited by 18
Narayan, J., Das, H. S., Nath, P., Singh, A., Mishra, D., Padhi, P. K., & Singh, S. P. (2020) · International Journal of Hepatology · doi:10.1155/2020/1825142 · Cited by 19
Stable isotope-based flux studies in nonalcoholic fatty liver disease
McCullough, A. J., Previs, S. F., & Kasumov, T. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.07.008 · Cited by 18
Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?
Marchesini, G., Petroni, M. L., & Cortez‐Pinto, H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.020 · Cited by 18
Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?
Finelli, C., & Tarantino, G. (2012) · Hepatology International · doi:10.1007/s12072-012-9406-z · Cited by 17
Umoh, U., Davies, C. J., & Adeleye, J. (2010) · Cited by 17
Furukawa, Y., Tamura, Y., Takeno, K., Funayama, T., Kaga, H., Suzuki, R., Watanabe, T., Kakehi, S., Kanazawa, A., Kawamori, R., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12731 · Cited by 16
Zhou, X., Ren, L., Yu, Z., Huang, X., Li, Y., & Wang, C. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.02.023 · Cited by 17
Non-Alcoholic Fatty Liver Disease and Vascular Disease
Forlano, R., Mullish, B. H., Nathwani, R., Dhar, A., Thursz, M. R., & Manousou, P. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200318103001 · Cited by 18
Metabolic flexibility across the spectrum of glycemic regulation in youth
Bacha, F. F., Bartz, S. K., Puyau, M. R., Adolph, A. L., & Sharma, S. (2021) · JCI Insight · doi:10.1172/jci.insight.146000 · Cited by 17
Chen, X., Duan, M., Hou, R., Zheng, M., Li, H., Singh, M., Li, C., Liu, K., Zhang, F., Yang, X., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s339066 · Cited by 18
Mechanisms for increased risk of diabetes in chronic liver diseases
Svegliati‐Baroni, G., Gaggini, M., Carli, F., Barbieri, C., Cucco, M., Younes, R., Rosso, C., Bugianesi, E., & Gastaldelli, A. (2020) · Liver International · doi:10.1111/liv.14556 · Cited by 17
Wang, T., Zuo, G., Yao, L., Yuan, C., Li, H., Lai, Y., Chen, Z., Zhang, J., Jin, Y., Yamahara, J., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10901 · Cited by 18
Ballato, E., Deepika, F., Russo, V., Fleires-Gutierrez, A. L., Colleluori, G., Fuenmayor, V., Chen, R., Villareal, D. T., Qualls, C., & Armamento‐Villareal, R. (2022) · Calcified Tissue International · doi:10.1007/s00223-022-00993-x · Cited by 16
Nah, B. K. Y., Ng, C. H., Chan, K. E., Tan, C., Aggarwal, M., Zeng, R. W., Xiao, J., Chin, Y. H., Tan, E. X. X., Ren, Y. P., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19169935 · Cited by 16
Pan, L., Gao, Y., Han, J., Li, L., Wang, M., Peng, H., Liao, J., Wan, H., Xiang, G., & Han, Y. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1046223 · Cited by 16
Effect of Pregnancy for Females Born Small on Later Life Metabolic Disease Risk
Tran, M., Gallo, L. A., Wadley, G. D., Jefferies, A. J., Moritz, K. M., & Wlodek, M. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045188 · Cited by 16
Relative Contributions of Ectopic Liver and Abdominal Fat Accumulation to Arterial Stiffness
Luo, Z., Zeng, Q., Luo, R., Wang, Y., & Ge, Q. (2015) · Endocrine Practice · doi:10.4158/ep14526.or · Cited by 16
CML/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver
Pang, Q., Sun, Z., Shao, C., Cai, H., Bao, Z., Wang, L., Li, L., Jing, L., Zhang, L., & Wang, Z. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.583943 · Cited by 16
Eriksson, J. W., Visvanathar, R., Kullberg, J., Strand, R., Skrtic, S., Ekström, S., Lubberink, M., Lundqvist, M., Katsogiannos, P., Pereira, M. J., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1359 · Cited by 16
Bello, O., Ladwa, M., Hakim, O., Marathe, C. S., Shojaee‐Moradie, F., Charles‐Edwards, G., Peacock, J. L., Umpleby, A. M., Amiel, S. A., & Goff, L. M. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0636 · Cited by 15
Insulin management in overweight or obese type 2 diabetes patients: the role of insulin glargine
Davies, M. J., & Khunti, K. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00844.x · Cited by 16
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Causation or Association
Bali, A. D., Rosenzveig, A., Frishman, W. H., & Aronow, W. S. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000537 · Cited by 16
Loss of EGFR contributes to high‐fat diet‐induced nonalcoholic fatty liver disease
Shao, F., Deng, H., Zhang, W., Ren, Z., Kang, Z., Ding, Z., Zhang, J., & Zang, Y. (2023) · FEBS Letters · doi:10.1002/1873-3468.14636 · Cited by 15
Smith, K., Taylor, G., Allerton, D. M., Brunsgaard, L. H., Davies, K. A. B., Stevenson, E., & West, D. J. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.696977 · Cited by 17
Approach to the Patient With Nonalcoholic Fatty Liver Disease
Belfort‐DeAguiar, R., Lomonaco, R., & Cusi, K. J. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac624 · Cited by 16
The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 15
Hartwich, J., Leszczynska-Golabek, I., Kieć‐Wilk, B., Siedlecka, D., Pérez‐Martínez, P., Marı́n, C., López‐Miranda, J., Tierney, A. C., Monagle, J. M., Roche, H. M., et al. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365511003663630 · Cited by 15
Fat mass largely contributes to insulin mediated glucose uptake in morbidly obese subjects
Gniuli, D., Gissey, G. C., Iaconelli, A., Leccesi, L., & Mingrone, G. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.99 · Cited by 15
Alwahsh, S. M., & Ramadori, G. P. (2015) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000280 · Cited by 13
Pathophysiology, Diagnostic Criteria, and Approaches to Type 2 Diabetes Remission
Khamis, A. M. (2023) · Cureus · doi:10.7759/cureus.33908 · Cited by 20
Kato, K., Suzuki, K., Aoki, C., Sagara, M., Niitani, T., Wakamatsu, S., Yanagi, K., & Aso, Y. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1317748 · Cited by 14
Klein, S., & Romijn, J. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00036-8 · Cited by 14
Shi, M., Liu, P., Li, J., Su, Y., Zhou, X., Wu, C., Chen, X., & Zheng, C. (2021) · Journal of Diabetes · doi:10.1111/1753-0407.13169 · Cited by 14
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 14
Visceral Adiposity, Insulin Resistance, and Type 2 Diabetes
Griffith, M. L., Younk, L. M., & Davis, S. N. (2010) · American Journal of Lifestyle Medicine · doi:10.1177/1559827609360959 · Cited by 14
Lundsgaard, A., Bojsen-Møller, K. N., & Kiens, B. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.08.005 · Cited by 14
Whelehan, G., Bello, O., Hakim, O., Ladwa, M., Umpleby, A. M., Amiel, S. A., Bodicoat, D. H., & Goff, L. M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15867 · Cited by 13
Body fat distribution: the answer to the apparent paradox of obesity in cardiology?
Borodkinа, D. A., Gruzdeva, O. V., Kvitkova, L. V., & Барбараш, О. Л. (2017) · Obesity and metabolism · doi:10.14341/omet201723-8 · Cited by 12
Ding, C., Chan, Z., Chooi, Y. C., Choo, J., Sadananthan, S. A., Michael, N., Velan, S. S., Leow, M. K., & Magkos, F. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00250.2018 · Cited by 14
Dose–response association of the ZJU index and fatty liver disease risk: A large cohort in China
Li, X., Qin, P., Cao, L., Lou, Y., Shi, J. C., Zhao, P., Wang, C., Ma, J., Xu, S., Peng, X., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15286 · Cited by 13
Rontoyanni, V. G., Malagaris, I., Herndon, D. N., Rivas, E., Capek, K. D., Delgadillo, A. D. J., Bhattarai, N., Elizondo, A., Voigt, C. D., Finnerty, C. C., et al. (2017) · Shock · doi:10.1097/shk.0000000000001074 · Cited by 13
Ethnicity and Weight Status Affect the Accuracy of Proxy Indices of Insulin Sensitivit
Alvarez, J. A., Bush, N. C., Hunter, G. R., Brock, D. W., & Gower, B. A. (2008) · Obesity · doi:10.1038/oby.2008.437 · Cited by 13
Li, F., Yuan, R., Zhang, J., Su, B., & Qi, X. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101025 · Cited by 12
Metadata
- Authors
- Gastaldelli, A., Cusi, K., Pettiti, M., Hardies, J., Miyazaki, Y., Berria, R., Buzzigoli, E., Sironi, A. M., Cersosimo, E., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Istituto di Fisiologia Clinica (IT)
- University of Pisa (IT)
- Corresponding author
- Gastaldelli, Amalia
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2007-08
- Volume
- 133
- Issue
- 2
- Pages
- 496-506
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2136226749
- Cited by
- 629
- References
- 43
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 33 · 2023: 40 · 2022: 40 · 2021: 40 · 2020: 27 · 2019: 41 · 2018: 36 · 2017: 47 · 2016: 34 · 2015: 26 · 2014: 39 · 2013: 37 · 2012: 33
- FWCI
- 16.58
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
- National Center for Research Resources (M01RR01346, M01RR001346)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- hepatic insulin resistance, visceral fat, liver fat, abdominal fat accumulation, type 2 diabetes, obesity, hepatic glucose production, gluconeogenesis, hepatic steatosis, hyperinsulinemic-euglycemic clamp, subcutaneous adipose tissue, hepatic lipid accumulation, hepatic lipogenesis, hepatic lipolysis
- MeSH terms
- Adult, Aging, Blood Glucose, Diabetes Mellitus, Type 2, Female, Gluconeogenesis, Humans, Insulin, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Magnetic Resonance Spectroscopy, Obesity, Glucose Clamp Technique, Body Mass Index, Abdominal Fat, Glycogenolysis, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review